Not So Fast | GenomeWeb

Not So Fast

Claims made by Hisashi Moriguchi — a visiting researcher at the University of Tokyo — about using modified stem cells to successfully treat a patient with terminal heart failure could be false, reports Nature News.

According to the article, Moriguchi says he had invented a method of reprogramming induced pluripotent stem cells using two chemicals. He also claimed that the iPS cells could be differentiated using a "supercooling method" that he invented.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.